IQVIA CFO Ron Bruehlman to Speak at the Morgan Stanley Annual Global Healthcare Conference on September 4, 2024
IQVIA Holdings Inc. (NYSE:IQV) has announced that its CFO, Ron Bruehlman, will be speaking at the Morgan Stanley Annual Global Healthcare Conference on September 4, 2024 at 10:00 a.m. ET in New York. This event presents an opportunity for investors and analysts to gain insights into IQVIA's financial strategies and market positioning.
The presentation will be accessible via a live audio webcast on IQVIA's Investor Relations website. For those unable to attend or listen live, a replay of the webcast will be made available later the same day, ensuring wide access to the information shared during the conference.
This appearance at a major healthcare conference underscores IQVIA's commitment to transparency and engagement with the investment community, potentially impacting investor sentiment and the company's stock performance.
IQVIA Holdings Inc. (NYSE:IQV) ha annunciato che il suo CFO, Ron Bruehlman, parlerà al Conferenza Annuale sulla Sanità Globale di Morgan Stanley il 4 settembre 2024 alle 10:00 a.m. ET a New York. Questo evento offre un'opportunità per investitori e analisti di ottenere approfondimenti sulle strategie finanziarie e sulla posizione di mercato di IQVIA.
La presentazione sarà accessibile tramite un webcast audio dal vivo sul sito web delle Relazioni con gli Investitori di IQVIA. Per coloro che non possono partecipare o ascoltare dal vivo, una registrazione del webcast sarà disponibile più tardi nello stesso giorno, garantendo un ampio accesso alle informazioni condivise durante la conferenza.
Questa apparizione a una conferenza sanitaria di grande importanza sottolinea l'impegno di IQVIA verso la trasparenza e il coinvolgimento con la comunità degli investitori, potenzialmente influenzando il sentiment degli investitori e le performance azionarie dell'azienda.
IQVIA Holdings Inc. (NYSE:IQV) ha anunciado que su CFO, Ron Bruehlman, hablará en la Conferencia Anual Global de Atención Médica de Morgan Stanley el 4 de septiembre de 2024 a las 10:00 a.m. ET en Nueva York. Este evento representa una oportunidad para que inversores y analistas obtengan información sobre las estrategias financieras y la posición de mercado de IQVIA.
La presentación será accesible a través de un webcast de audio en vivo en el sitio web de Relaciones con Inversores de IQVIA. Para aquellos que no puedan asistir o escuchar en vivo, se dispondrá de una repetición del webcast más tarde el mismo día, asegurando un amplio acceso a la información compartida durante la conferencia.
Esta aparición en una importante conferencia de salud subraya el compromiso de IQVIA con la transparencia y el compromiso con la comunidad inversora, lo que podría afectar el sentimiento de los inversores y el rendimiento de las acciones de la empresa.
IQVIA Holdings Inc. (NYSE:IQV)는 CFO Ron Bruehlman이 모건 스탠리 연례 글로벌 헬스케어 컨퍼런스에서 2024년 9월 4일 오전 10:00 ET에 뉴욕에서 연설할 것이라고 발표했습니다. 이 행사는 투자자와 분석가들이 IQVIA의 재무 전략과 시장 포지션에 대한 통찰을 얻을 수 있는 기회를 제공합니다.
발표는 IQVIA의 투자자 관계 웹사이트에서 라이브 오디오 웹캐스트를 통해 접근할 수 있습니다. 참석하지 않거나 생중계 청취가 불가능한 분들을 위해서는 같은 날 저녁에 웹캐스트의 재방송이 제공되어 회의 중 공유된 정보에 대한 접근성을 보장합니다.
주요 헬스케어 컨퍼런스에서의 이 참석은 IQVIA의 투명성과 투자자 커뮤니티와의 참여에 대한 약속을 강조하며, 이는 투자자 심리와 회사 주가에 잠재적으로 영향을 미칠 수 있습니다.
IQVIA Holdings Inc. (NYSE:IQV) a annoncé que son CFO, Ron Bruehlman, prendra la parole lors de la Conférence Annuelle Mondiale sur la Santé de Morgan Stanley le 4 septembre 2024 à 10h00 ET à New York. Cet événement offre aux investisseurs et aux analystes une occasion d'acquérir des informations sur les stratégies financières et le positionnement sur le marché d'IQVIA.
La présentation sera accessible via un webinaire audio en direct sur le site des Relations Investisseurs d'IQVIA. Pour ceux qui ne peuvent pas assister ou écouter en direct, un replay du webinaire sera disponible plus tard dans la journée, garantissant un large accès aux informations partagées lors de la conférence.
Cette apparition à une conférence majeure sur la santé souligne l'engagement d'IQVIA envers la transparence et l'engagement avec la communauté des investisseurs, ce qui pourrait avoir un impact sur le sentiment des investisseurs et la performance boursière de l'entreprise.
IQVIA Holdings Inc. (NYSE:IQV) hat bekannt gegeben, dass der CFO Ron Bruehlman am Morgan Stanley Annual Global Healthcare Conference am 4. September 2024 um 10:00 Uhr ET in New York sprechen wird. Diese Veranstaltung bietet Investoren und Analysten die Möglichkeit, Einblicke in die Finanzstrategien und die Marktposition von IQVIA zu gewinnen.
Die Präsentation wird über ein Live-Audio-Webcast auf der Investor Relations-Website von IQVIA zugänglich sein. Für diejenigen, die nicht teilnehmen oder live zuhören können, wird eine Wiederholung des Webcasts später am selben Tag verfügbar sein, um einen breiten Zugang zu den während der Konferenz geteilten Informationen zu gewährleisten.
Dieser Auftritt auf einer bedeutenden Gesundheitskonferenz unterstreicht IQVIAs Engagement für Transparenz und den Dialog mit der Investoren-Community, was potenziell die Stimmung der Investoren und die Aktienleistung des Unternehmens beeinflussen könnte.
- None.
- None.
A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
IQVIAFIN
View source version on businesswire.com: https://www.businesswire.com/news/home/20240821968776/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)
+1.919.780.3221
Source: IQVIA Holdings Inc.
FAQ
When is IQVIA's CFO speaking at the Morgan Stanley Annual Global Healthcare Conference?
How can investors listen to IQVIA's presentation at the healthcare conference?
Will there be a replay available of IQVIA's presentation at the Morgan Stanley conference?
What is the stock symbol for IQVIA Holdings Inc.?
